Chu De Quebec-universite Laval
Clinical trials sponsored by Chu De Quebec-universite Laval, explained in plain language.
-
Fish oil fights prostate cancer inflammation in new trial
Disease control OngoingThis study tests whether taking omega-3 (EPA) supplements can reduce inflammation and improve quality of life in men with high-risk prostate cancer who choose surgery. 130 participants will take either fish oil or placebo capsules for six weeks before and one year after prostate …
Phase: PHASE2 • Sponsor: CHU de Quebec-Universite Laval • Aim: Disease control
Last updated May 26, 2026 03:25 UTC
-
Fish oil fights back: Omega-3 may delay hormone therapy in prostate cancer
Disease control OngoingThis study tests whether a daily high-dose omega-3 supplement (fish oil) can slow the rise of PSA levels in men whose prostate cancer has returned after initial treatment. About 40 men with a rising PSA but no visible spread will take either the supplement or a placebo for one ye…
Phase: PHASE2 • Sponsor: CHU de Quebec-Universite Laval • Aim: Disease control
Last updated May 26, 2026 03:04 UTC
-
Custom skin patch offers hope for rare blistering condition
Disease control OngoingThis study tests a lab-made skin substitute on one patient with dystrophic epidermolysis bullosa, a rare disease causing fragile skin and chronic wounds. The goal is to cover open sores that haven't healed with standard treatments. Researchers will measure wound shrinkage, healin…
Phase: EARLY_PHASE1 • Sponsor: CHU de Quebec-Universite Laval • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
Starving cancer of cholesterol: new combo shows promise in early trial
Disease control OngoingThis study tests whether adding three cholesterol-lowering drugs (atorvastatin, ezetimibe, and evolocumab) to standard chemotherapy can slow or stop pancreatic cancer growth. It involves 3 adults with newly diagnosed advanced or metastatic pancreatic cancer. The goal is to see if…
Phase: EARLY_PHASE1 • Sponsor: CHU de Quebec-Universite Laval • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
New radiation schedule aims to cut prostate cancer treatment time without increasing side effects
Disease control TerminatedThis study tests a shorter, more intense radiation schedule (ultra-hypo fractionated) against the standard longer course for prostate cancer that has spread to pelvic lymph nodes. About 500 men will receive either the new or standard radiation, plus a brachytherapy boost and horm…
Phase: NA • Sponsor: CHU de Quebec-Universite Laval • Aim: Disease control
Last updated May 20, 2026 11:57 UTC
-
New PET scan spots prostate cancer spread standard scans miss
Diagnosis OngoingThis study tested a special PET scan (18F-DCFPyL) to see if it could find cancer spread in 50 men with castration-resistant prostate cancer whose standard scans were negative or unclear. The goal was to improve detection of hidden metastases. Results may help doctors choose bette…
Phase: PHASE2 • Sponsor: CHU de Quebec-Universite Laval • Aim: Diagnosis
Last updated May 26, 2026 03:04 UTC
-
Your diet and exercise may predict prostate cancer risk
Prevention OngoingThis study explores how lifestyle factors like diet and physical activity affect prostate cancer risk in over 2000 men. Researchers aim to identify biological markers that can help personalize prevention strategies. Participants are men at high risk for prostate cancer, either wi…
Sponsor: CHU de Quebec-Universite Laval • Aim: Prevention
Last updated May 26, 2026 03:12 UTC
-
Early diet intervention may slash gestational diabetes risk
Prevention OngoingThis study tests whether a healthy eating program starting in the first trimester can improve blood sugar control in 150 pregnant women at risk for gestational diabetes. Participants receive personalized nutrition counseling, online resources, and support through a private Facebo…
Phase: NA • Sponsor: CHU de Quebec-Universite Laval • Aim: Prevention
Last updated May 22, 2026 14:01 UTC
-
Fish oil and drug combo may slow prostate cancer in Low-Risk men
Prevention OngoingThis study looks at whether taking marine omega-3 fatty acids (found in fish oil) and a drug called dutasteride can slow or prevent prostate cancer from getting worse in men with low-risk prostate cancer. The 120 participants are already on active surveillance, meaning they are c…
Phase: NA • Sponsor: CHU de Quebec-Universite Laval • Aim: Prevention
Last updated May 22, 2026 13:52 UTC